175 related articles for article (PubMed ID: 28443460)
21. Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.
Ji X; Zhu H; Dai X; Xi Y; Sheng Y; Gao C; Liu H; Xue Y; Liu J; Shi J; Zhang Y; Chen Y; Dai X; Li M; Wang A; Dong J
Cancer Biomark; 2019; 25(3):275-290. PubMed ID: 29991124
[TBL] [Abstract][Full Text] [Related]
22. MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5a.
Zhao D; Wang R; Fang J; Ji X; Li J; Chen X; Sun G; Wang Z; Liu W; Wang Y; Cheng G; Zhen H; Sun C; Fei Z
Mol Neurobiol; 2017 May; 54(4):2823-2830. PubMed ID: 27013470
[TBL] [Abstract][Full Text] [Related]
23. Transient RUNX1 Expression during Early Mesendodermal Differentiation of hESCs Promotes Epithelial to Mesenchymal Transition through TGFB2 Signaling.
VanOudenhove JJ; Medina R; Ghule PN; Lian JB; Stein JL; Zaidi SK; Stein GS
Stem Cell Reports; 2016 Nov; 7(5):884-896. PubMed ID: 27720906
[TBL] [Abstract][Full Text] [Related]
24. Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect.
Velpula KK; Bhasin A; Asuthkar S; Tsung AJ
Cancer Res; 2013 Dec; 73(24):7277-89. PubMed ID: 24148623
[TBL] [Abstract][Full Text] [Related]
25. Moesin Up-regulation Is Associated with Enhanced Tumor Progression Imaged Non-invasively in an Orthotopic Mouse Model of Human Glioblastoma.
Wang Q; Lu X; Wang J; Yang Z; Hoffman RM; Wu X
Anticancer Res; 2018 Jun; 38(6):3267-3272. PubMed ID: 29848673
[TBL] [Abstract][Full Text] [Related]
26. Runt-related transcription factor 1 contributes to lung cancer development by binding to tartrate-resistant acid phosphatase 5.
He C; Bai X; Li Y; Sun H; Kong X; Fu B; Chen L; Zhu K; Li P; Xu S
Cell Cycle; 2019 Dec; 18(23):3404-3419. PubMed ID: 31650885
[TBL] [Abstract][Full Text] [Related]
27. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.
Qiu W; Xiao Z; Yang Y; Jiang L; Song S; Qi X; Chen Y; Yang H; Liu J; Chu L
Cell Death Dis; 2023 Mar; 14(3):207. PubMed ID: 36949071
[TBL] [Abstract][Full Text] [Related]
28. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES
Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
[TBL] [Abstract][Full Text] [Related]
30. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.
Akiyama Y; Ashizawa T; Komiyama M; Miyata H; Oshita C; Omiya M; Iizuka A; Kume A; Sugino T; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Jul; 32(1):159-66. PubMed ID: 24842123
[TBL] [Abstract][Full Text] [Related]
31. Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models.
Teng J; da Hora CC; Kantar RS; Nakano I; Wakimoto H; Batchelor TT; Chiocca EA; Badr CE; Tannous BA
Neuro Oncol; 2017 Jun; 19(6):820-832. PubMed ID: 28062830
[TBL] [Abstract][Full Text] [Related]
32. Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.
Sa JK; Kim SH; Lee JK; Cho HJ; Shin YJ; Shin H; Koo H; Kim D; Lee M; Kang W; Hong SH; Kim JY; Park YW; Song SW; Lee SJ; Joo KM; Nam DH
Neuro Oncol; 2019 Feb; 21(2):222-233. PubMed ID: 29939324
[TBL] [Abstract][Full Text] [Related]
33. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
[TBL] [Abstract][Full Text] [Related]
34. MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation.
Lu Y; Xiao L; Liu Y; Wang H; Li H; Zhou Q; Pan J; Lei B; Huang A; Qi S
Autophagy; 2015; 11(12):2213-32. PubMed ID: 26553592
[TBL] [Abstract][Full Text] [Related]
35. RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.
Sangpairoj K; Vivithanaporn P; Apisawetakan S; Chongthammakun S; Sobhon P; Chaithirayanon K
Cell Mol Neurobiol; 2017 Oct; 37(7):1243-1255. PubMed ID: 28012022
[TBL] [Abstract][Full Text] [Related]
36. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-300 inhibited glioblastoma progression through ROCK1.
Zhou F; Li Y; Hao Z; Liu X; Chen L; Cao Y; Liang Z; Yuan F; Liu J; Wang J; Zheng Y; Dong D; Bian S; Yang B; Jiang C; Li Q
Oncotarget; 2016 Jun; 7(24):36529-36538. PubMed ID: 27145462
[TBL] [Abstract][Full Text] [Related]
38. Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA.
Heo JC; Jung TH; Lee S; Kim HY; Choi G; Jung M; Jung D; Lee HK; Lee JO; Park JH; Hwang D; Seol HJ; Cho H
Clin Exp Metastasis; 2016 Jun; 33(5):417-29. PubMed ID: 26957434
[TBL] [Abstract][Full Text] [Related]
39. Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function.
Kim K; Lee S; Kang H; Shin E; Kim HY; Youn H; Youn B
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804169
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression.
Fedele V; Dai F; Masilamani AP; Heiland DH; Kling E; Gätjens-Sanchez AM; Ferrarese R; Platania L; Soroush D; Kim H; Nelander S; Weyerbrock A; Prinz M; Califano A; Iavarone A; Bredel M; Carro MS
Mol Cancer Res; 2017 Aug; 15(8):998-1011. PubMed ID: 28512252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
